Showing results (31-40 of 285) with videos related to
Sort By:
Pageof 29
The International Journal of Biochemistry & Cell Biology|February 22, 2008
The molecular aetiology of the serpinopathiesMark J Davies, David A LomasDrug Design, Development and Therapy|October 4, 2011
Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesisJennifer A Dickens, David A LomasTrends in Cell Biology|January 25, 2008
Intracellular serpins, firewalls and tissue necrosisStefan J Marciniak, David A LomasJournal of Molecular Biology|February 13, 2003
Structure of beta-antithrombin and the effect of glycosylation on antithrombin's heparin affinity and activityAirlie J McCoy, Xue Yuan Pei, Richard Skinner, et al.Nature Structural Biology|June 17, 2003
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migrationAiwu Zhou, James A Huntington, Navraj S Pannu, et al.The International Journal of Biochemistry & Cell Biology|April 4, 2003
Alpha(1)-antitrypsin deficiency, liver disease and emphysemaHelen Parfrey, Ravi Mahadeva, David A LomasThe Journal of Biological Chemistry|April 20, 2004
Mutants of neuroserpin that cause dementia accumulate as polymers within the endoplasmic reticulumElena Miranda, Karin Römisch, David A LomasThe Journal of Biological Chemistry|December 14, 2001
Helix D elongation and allosteric activation of antithrombinKlara J Belzar, Aiwu Zhou, Robin W Carrell, et al.Proceedings of the National Academy of Sciences of the United States of America|August 10, 2002
Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanismTrevor P Baglin, Robin W Carrell, Frank C Church, et al.Pageof 29